- Vouliez-vous dire
- performed
Résultats de la recherche - 18 results
Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.
whole female population were obtained from the two cancer registries. During 2008-2011, 565 153 smears were performed in 498 913 women aged 25-64 years, representing an average of 1.13 smears/woman and ...
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
HPV assays with genotyping capability. In VALGENT-3, the clinical and analytical performance of Anyplex II HPV HR detection (Anyplex) was compared to that of the Hybrid Capture 2 HPV DNA test (hc2) and ...
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
Neoplasms Abstract: In this diagnostic test validation study, we assessed the clinical accuracy and HPV genotyping performance of the INNO-LiPA HPV Genotyping II (INNO-LiPA) within the VALGENT-3 framework. ...
The use of the permanent sample (eps) to study the returnto- work after cancer. Challenges and opportunities for research
We suggest some modifications of the EPS that might offer scientists better opportunities to improve the performance and reliability of such cohort studies. Health Topics: Cancer Quality of healthcare ...
Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.
with an internal control probe. Here, we present an analysis of the clinical performance of the LMNX using a sample panel and infrastructure provided by the international VALGENT (Validation of ...
Description of cervical cancer mortality in Belgium using Bayesian age-period-cohort models.
the Netherlands was applied to Belgian uterus cancer deaths to estimate the corrected number of cervix cancer deaths (corCVX). A Bayesian loglinear Poisson-regression model was performed to disentangle ...
Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening.
high numbers performed without previous cytology result is not in line with the internationally agreed recommendations, where colposcopies should be used to examine women with abnormal cytology findings. ...
Chapter 10: HPV testing on cervical cancer specimens: which assay can be used in cervical cancer screening.
screening programmes need to know which HPV tests are credible and have evidence-based performance in primary screening. Systematic reviews have assessed which high-risk HPV DNA tests are sufficiently ...